Federated Hermes’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-14,292
| Closed | -$2.36M | – | 2379 |
|
|
2021
Q2 | $2.36M | Buy |
14,292
+1,274
| +10% | +$213K | ﹤0.01% | 1038 |
|
|
2021
Q1 | $2M | Sell |
13,018
-231,022
| -95% | -$31.4M | ﹤0.01% | 1105 |
|
|
2020
Q4 | $30.6M | Buy |
244,040
+24,190
| +11% | +$2.71M | 0.06% | 351 |
|
|
2020
Q3 | $22.3M | Buy |
219,850
+2,738
| +1% | +$279K | 0.05% | 387 |
|
|
2020
Q2 | $21.1M | Sell |
217,112
-34,484
| -14% | -$3.21M | 0.05% | 383 |
|
|
2020
Q1 | $20.9M | Buy |
251,596
+131,146
| +109% | +$12.8M | 0.06% | 325 |
|
|
2019
Q4 | $13.4M | Sell |
120,450
-1,251
| -1% | -$129K | 0.03% | 530 |
|
|
2019
Q3 | $12.1M | Sell |
121,701
-21,977
| -15% | -$2.18M | 0.03% | 512 |
|
|
2019
Q2 | $14.2M | Sell |
143,678
-224,341
| -61% | -$21.4M | 0.03% | 459 |
|
|
2019
Q1 | $40.6M | Buy |
368,019
+29,003
| +9% | +$3.03M | 0.1% | 220 |
|
|
2018
Q4 | $31.2M | Sell |
339,016
-6,913
| -2% | -$699K | 0.09% | 248 |
|
|
2018
Q3 | $38.1M | Sell |
345,929
-3,452
| -1% | -$359K | 0.09% | 234 |
|
|
2018
Q2 | $32.6M | Sell |
349,381
-87,458
| -20% | -$7.53M | 0.1% | 178 |
|
|
2018
Q1 | $36.2M | Sell |
436,839
-103,401
| -19% | -$9.19M | 0.11% | 165 |
|
|
2017
Q4 | $49.2M | Buy |
540,240
+439,820
| +438% | +$36.6M | 0.14% | 133 |
|
|
2017
Q3 | $7.65M | Buy |
100,420
+68,229
| +212% | +$5.16M | 0.02% | 457 |
|
|
2017
Q2 | $2.42M | Sell |
32,191
-1,178
| -4% | -$81.7K | 0.01% | 827 |
|
|
2017
Q1 | $2.18M | Buy |
33,369
+12,888
| +63% | +$759K | 0.01% | 876 |
|
|
2016
Q4 | $1.13M | Buy |
20,481
+11,261
| +122% | +$618K | ﹤0.01% | 1093 |
|
|
2016
Q3 | $521K | Sell |
9,220
-26,547
| -74% | -$1.3M | ﹤0.01% | 1268 |
|
|
2016
Q2 | $1.49M | Sell |
35,767
-7,485
| -17% | -$345K | ﹤0.01% | 963 |
|
|
2016
Q1 | $1.85M | Buy |
43,252
+2,847
| +7% | +$120K | 0.01% | 864 |
|
|
2015
Q4 | $1.83M | Buy |
40,405
+19,812
| +96% | +$832K | 0.01% | 911 |
|
|
2015
Q3 | $800K | Buy |
+20,593
| New | +$824K | ﹤0.01% | 1150 |
|
Other funds holding PRAH
Federated Hermes's PRAH Position: Q3 2021 in Review
Federated Hermes sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 14,292 shares — an estimated $2.36M sold.
Federated Hermes first reported a position in PRAH in Q3 2015 and held it in 24 quarters. The position peaked at $49.2M in Q4 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Federated Hermes reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Federated Hermes sold 14,292 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.36M.
- Federated Hermes first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 24 quarters.
- Federated Hermes's PRA Health Sciences, Inc. position peaked at $49.2M in Q4 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.